Literature DB >> 1432264

Altered zinc metabolism occurs in murine lethal milk syndrome.

D Y Lee1, N F Shay, R J Cousins.   

Abstract

The lethal milk (lm) mutation in mice causes Zn deficiency in pups nursed by lm dams. To examine tissue Zn distribution and Zn transport to milk and pups, 65Zn was administered to lactating normal and lm dams. Transport of 65Zn to milk of lm dams was approximately 50% of that transported to milk of normal dams. The lower milk 65Zn resulted in significantly less 65Zn uptake by tissues of the nursing pups. The decrease in 65Zn transport to the milk was accompanied by a significant increase in 65Zn uptake and metallothionein mRNA levels in kidney of the lm dams. The elevated Zn uptake and metallothionein expression was tissue specific and could be a reflection of altered zinc transport from mammary gland to milk. Polyacrylamide gel electrophoresis and Western transfer of mammary gland proteins from lm dams showed that a 30-kDa protein bound more 65Zn in vitro compared with proteins from normal mammary gland. Normal pups nursed by dams of the lm genotype had down-regulated metallothionein expression due to Zn deficiency. The genetic defect in lm mice decreases Zn transport to milk, thus explaining the neonatal Zn deficiency seen in normal mice fostered by lm dams. The greater metallothionein expression in dams of the lm genotype could be a secondary manifestation of altered tissue zinc distribution or a primary effect on a metallothionein regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432264     DOI: 10.1093/jn/122.11.2233

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  8 in total

1.  Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk.

Authors:  Loveleen Kumar; Agnes Michalczyk; Jill McKay; Dianne Ford; Taiho Kambe; Lee Hudek; George Varigios; Philip E Taylor; M Leigh Ackland
Journal:  Genes Nutr       Date:  2015-08-29       Impact factor: 5.523

2.  A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency.

Authors:  Inbal Lasry; Young Ah Seo; Hadas Ityel; Nechama Shalva; Ben Pode-Shakked; Fabian Glaser; Bluma Berman; Igor Berezovsky; Alexander Goncearenco; Aharon Klar; Jacob Levy; Yair Anikster; Shannon L Kelleher; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

3.  Constitutive expression of hZnT4 zinc transporter in human breast epithelial cells.

Authors:  Agnes A Michalczyk; Justin Allen; Rachael C Blomeley; M Leigh Ackland
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 4.  Analysis of lactation defects in transgenic mice.

Authors:  Carol A Palmer; Margaret C Neville; Steven M Anderson; James L McManaman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

5.  Zinc deficiency and its inherited disorders -a review.

Authors:  M Leigh Ackland; Agnes Michalczyk
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

6.  The Znt4 mutation inlethal milk mice affects intestinal zinc homeostasis through the expression of other Zn transporters.

Authors:  Chiara Murgia; Isabella Vespignani; Rita Rami; Giuditta Perozzi
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

7.  Analysis of zinc transporter, hZnT4 ( Slc30A4), gene expression in a mammary gland disorder leading to reduced zinc secretion into milk.

Authors:  Agnes Michalczyk; George Varigos; Anthony Catto-Smith; Rachael C Blomeley; M Leigh Ackland
Journal:  Hum Genet       Date:  2003-05-13       Impact factor: 4.132

8.  Transient Neonatal Zinc Deficiency Caused by a Heterozygous G87R Mutation in the Zinc Transporter ZnT-2 (SLC30A2) Gene in the Mother Highlighting the Importance of Zn (2+) for Normal Growth and Development.

Authors:  Maria Consolata Miletta; Andreas Bieri; Kristin Kernland; Martin H Schöni; Vibor Petkovic; Christa E Flück; Andrée Eblé; Primus E Mullis
Journal:  Int J Endocrinol       Date:  2013-09-29       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.